- Home
- PCB vs MRVI Comparison
PCB vs MRVI Comparison
Compare PCB & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- MRVI
- Stock Information
- Founded
- PCB 2003
- MRVI 2014
- Country
- PCB United States
- MRVI United States
- Employees
- PCB N/A
- MRVI 560
- Industry
- PCB Major Banks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- PCB Finance
- MRVI Health Care
- Exchange
- PCB Nasdaq
- MRVI Nasdaq
- Market Cap
- PCB 289.7M
- MRVI 350.1M
- IPO Year
- PCB N/A
- MRVI 2020
- Fundamental
- Price
- PCB $22.10
- MRVI $2.42
- Analyst Decision
- PCB Hold
- MRVI Hold
- Analyst Count
- PCB 2
- MRVI 10
- Target Price
- PCB $22.25
- MRVI $5.84
- AVG Volume (30 Days)
- PCB 26.5K
- MRVI 1.5M
- Earning Date
- PCB 10-23-2025
- MRVI 08-11-2025
- Dividend Yield
- PCB 3.62%
- MRVI N/A
- EPS Growth
- PCB 29.75
- MRVI N/A
- EPS
- PCB 2.14
- MRVI N/A
- Revenue
- PCB $102,259,000.00
- MRVI $219,830,000.00
- Revenue This Year
- PCB $22.59
- MRVI N/A
- Revenue Next Year
- PCB $9.32
- MRVI $7.23
- P/E Ratio
- PCB $10.33
- MRVI N/A
- Revenue Growth
- PCB 9.08
- MRVI N/A
- 52 Week Low
- PCB $16.00
- MRVI $1.67
- 52 Week High
- PCB $22.45
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- PCB 57.65
- MRVI 49.60
- Support Level
- PCB $21.97
- MRVI $2.28
- Resistance Level
- PCB $22.41
- MRVI $2.47
- Average True Range (ATR)
- PCB 0.38
- MRVI 0.14
- MACD
- PCB 0.05
- MRVI -0.01
- Stochastic Oscillator
- PCB 73.08
- MRVI 27.45
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.